What is the recommended management for a 6‑ to 12‑month‑old infant with hypospadias, including timing of surgery, choice of repair technique based on lesion location, use of pre‑operative testosterone, and postoperative care?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Hypospadias in 6- to 12-Month-Old Infants

For a 6- to 12-month-old infant with hypospadias, perform surgical repair between 6-18 months of age, reserve preoperative testosterone only for proximal cases with small glans diameter (<14 mm), select repair technique based on curvature severity and lesion location, and avoid routine prophylactic antibiotics in distal repairs. 1

Timing of Surgery

The optimal surgical window is 6-18 months of age for primary hypospadias repair 1. This timing balances:

  • Adequate penile size for surgical manipulation
  • Completion before memory formation and toilet training
  • Minimization of psychological impact

While the American Academy of Pediatrics recommends 6-12 months, extending to 18 months remains acceptable 2. Delaying beyond 18 months increases complication rates, particularly fistula formation, which occurs more frequently in children ≥4 years old 3.

Common Pitfall

Do not delay surgery waiting for "optimal" conditions—the 6-18 month window represents the best balance of technical feasibility and long-term outcomes.

Preoperative Testosterone Use

The evidence for preoperative hormone therapy is equivocal 1. Current guideline-based recommendations:

Indications (Limited and Specific)

  • Proximal hypospadias with small glans diameter (<14 mm) 1, 4
  • Severe ventral curvature requiring tissue augmentation
  • NOT indicated for routine distal hypospadias

Regimen When Used

  • Intramuscular testosterone enanthate: 2 mg/kg monthly for 2 months 5
  • Topical testosterone gel 2%: 2 mg/day for approximately 43 days 4
  • Surgery should be delayed 4-8 weeks after final testosterone dose to allow vascularity to normalize and prevent wound healing complications 6, 4

Expected Effects

  • Glans width increase: 4-10 mm (sustained >12 months post-treatment) 6
  • Penile length increase: 22-37% 5
  • Complication reduction in select studies (5.5% vs 13.2%) 5

Side Effects (Temporary)

  • Genital pigmentation (universal)
  • Scant pubic hair (common)
  • All resolve within 3 months post-treatment 5

Critical Nuance

The benefit of testosterone remains controversial—some studies show reduced complications 5, while guidelines emphasize equivocal evidence 1. Use selectively, not routinely.

Surgical Technique Selection

Choice depends on curvature severity and meatal location:

Distal Hypospadias (Success Rate: 85-90%)

Tubularized Incised Plate (TIP) Procedure 1

  • Only if curvature <30° (critical threshold) 1
  • Preserves urethral plate with midline incision
  • Exceeding 30° curvature dramatically increases recurrence risk (26%) 1

Proximal Hypospadias (Success Rate: 32-86%)

Algorithm for Proximal Repair:

  1. Assess curvature after degloving and ventral tissue excision 1

  2. If curvature >30°:

    • Avoid TIP (26% ventral curvature recurrence) 1
    • Avoid urethral plate mobilization without transection (20% recurrence, 17% stricture) 1
  3. Curvature correction technique:

    • Ventral lengthening preferred over dorsoplication for severe curvature (5% vs 25% recurrence) 1
    • Options: corporotomy with/without grafting
  4. Urethroplasty approach:

    • Staged procedures increasingly preferred for proximal cases 1
    • Lower ventral curvature recurrence
    • Better long-term outcomes despite variable complication rates
    • Second-layer neourethral coverage mandatory (minimizes fistula) 1

Technical Considerations

  • Inlay grafts reduce meatal stenosis by 66% 1
  • Preputial reconstruction acceptable if foreskin not needed (7-17% dehiscence risk) 1

Postoperative Care

Stenting and Dressing

  • Type of stent/dressing does NOT impact outcomes 1
  • No consensus on optimal duration—surgeon preference 1
  • Dripping-stent into double diaper effective in infants 7

Antibiotic Prophylaxis

Do NOT use routine prophylactic antibiotics in distal hypospadias repair—they do not reduce surgical site infection or UTI rates 1. This represents clear, evidence-based guidance against common practice.

Follow-Up Requirements

Long-term follow-up is essential 1:

  • Significant late complications reported
  • 48% reoperation rate within 15 years for proximal hypospadias 1
  • Monitor for obstructive flow patterns
  • Assess psychosexual outcomes into adolescence 8

Expected Complications

Overall Rates

  • Primary repairs: 12.2% 1
  • Repeat repairs: 23.3% 1

Specific Complications

  • Urethrocutaneous fistula: 5-50% (most common) 1
  • Meatal stenosis: 5-15% 1
  • Urethral stricture: 8-13% (especially proximal repairs) 1
  • Glans dehiscence: 9-17% (small glans <14 mm, proximal cases; rarely affects function) 1

Risk Factors for Complications

  • Proximal location
  • Small glans diameter (<14 mm)
  • Curvature >30° treated with TIP
  • Age >4 years at surgery 3

Critical Decision Points Summary

  1. Age 6-18 months: Proceed with surgery
  2. Glans <14 mm + proximal: Consider testosterone (delay surgery 4-8 weeks post-treatment)
  3. Curvature assessment: <30° = TIP possible; >30° = staged/ventral lengthening
  4. Proximal cases: Favor staged procedures with second-layer coverage
  5. Postoperative: No routine antibiotics for distal repairs; mandatory long-term follow-up

1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.